GYG2 and Leigh syndrome: Similarly, GYG2 mutation has been characterized as a pathogenic mutation in human Leigh syndrome, an early-onset progressive neurodegenerative disorder resulting from defective glycogen synthesis (Imagawa et al. 2014).